A Year in Review: 2015 505(b)(2) NDA Approvals

Camargo recently published a thorough review of the 2015 505(b)(2) NDA approvals. There are a lot of interesting statistics to glean from this summary. With 44 505(b)(2) approvals in 2015, one thing is clear: drug repurposing continues to play an important role in drug development.

To read more, check out the following link: http://blog.camargopharma.com/index.php/2016/02/04/2015-505b2-nda-approvals/